Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Oct;34(10):1986–1990. doi: 10.1128/aac.34.10.1986

Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides.

E Matthes 1, P Langen 1, M von Janta-Lipinski 1, H Will 1, H C Schröder 1, H Merz 1, B E Weiler 1, W E Müller 1
PMCID: PMC171976  PMID: 2291664

Abstract

2',3'-Dideoxy-3'-fluorothymidine (FddThd), 2',3'-didehydro-2',3'- dideoxythymidine (ddeThd), and 3'-fluoro-5-methyl-deoxycytidine (FddMeCyt) are, in their triphosphate forms, selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase. We report that 0.3 microM FddThd, FddMeCyt, or ddeThd as well as 3'-chloro-5-methyl-deoxycytidine (ClddMeCyt) or 3'-amino-5-methyl-deoxycytidine (AddMeCyt) almost completely blocked production of hepatitis B virus (HBV) particles by HBV DNA-transfected cell line 2.2.15 in vitro. Only at an at least 10-fold-higher concentration was a cytotoxic effect observed. These results indicate that FddThd, FddMeCyt, ClddMeCyt, AddMeCyt, and ddeThd are potent anti-HBV agents in vitro.

Full text

PDF
1987

Images in this article

1988Image
on p.1988
1989Image
on p.1989

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bollum F. J. Mammalian DNA polymerases. Prog Nucleic Acid Res Mol Biol. 1975;15(0):109–144. doi: 10.1016/s0079-6603(08)60118-x. [DOI] [PubMed] [Google Scholar]
  2. De Clercq E. Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses. Cancer Lett. 1979 Nov;8(1):9–22. doi: 10.1016/0304-3835(79)90017-x. [DOI] [PubMed] [Google Scholar]
  3. Gerber M. A., Thung S. N. Molecular and cellular pathology of hepatitis B. Lab Invest. 1985 Jun;52(6):572–590. [PubMed] [Google Scholar]
  4. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol. 1967 Jun 14;26(2):365–369. doi: 10.1016/0022-2836(67)90307-5. [DOI] [PubMed] [Google Scholar]
  5. Horwitz J. R., Chua J., Da Rooge M. A., Noel M., Klundt I. L. Nucleosides. IX. The formation of 2',2'-unsaturated pyrimidine nucleosides via a novel beta-elimination reaction. J Org Chem. 1966 Jan;31(1):205–211. doi: 10.1021/jo01339a045. [DOI] [PubMed] [Google Scholar]
  6. Jochum C., Voth R., Rossol S., Meyer zum Büschenfelde K. H., Hess G., Will H., Schröder H. C., Steffen R., Müller W. E. Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J Virol. 1990 May;64(5):1956–1963. doi: 10.1128/jvi.64.5.1956-1963.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kakumu S., Tahara H., Fuji A., Yoshioka K. Interleukin 1 alpha production by peripheral blood monocytes from patients with chronic liver disease and effect of sera on interleukin 1 alpha production. J Clin Lab Immunol. 1988 Jul;26(3):113–119. [PubMed] [Google Scholar]
  8. Langen P., Kowollik G., Etzold G., Venner H., Reinert H. The phosphorylation of 3'-deoxy-3'-fluorothymidine and its incorporation into DNA in a cellfree system from tumor cells. Acta Biol Med Ger. 1972;29(4):483–494. [PubMed] [Google Scholar]
  9. Marier R. The reporting of communicable diseases. Am J Epidemiol. 1977 Jun;105(6):587–590. doi: 10.1093/oxfordjournals.aje.a112424. [DOI] [PubMed] [Google Scholar]
  10. Matthes E., Lehmann C., Scholz D., Rosenthal H. A., Langen P. Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine. Biochem Biophys Res Commun. 1988 Jun 16;153(2):825–831. doi: 10.1016/s0006-291x(88)81170-7. [DOI] [PubMed] [Google Scholar]
  11. Matthes E., Lehmann C., Scholz D., von Janta-Lipinski M., Gaertner K., Rosenthal H. A., Langen P. Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5'-triphosphate in comparison to cellular DNA polymerases alpha and beta. Biochem Biophys Res Commun. 1987 Oct 14;148(1):78–85. doi: 10.1016/0006-291x(87)91078-3. [DOI] [PubMed] [Google Scholar]
  12. Meisel H., Reimer K., von Janta-Lipinski M., Bärwolff D., Matthes E. Inhibition of hepatitis B virus DNA polymerase by 3'-fluorothymidine triphosphate and other modified nucleoside triphosphate analogs. J Med Virol. 1990 Feb;30(2):137–141. doi: 10.1002/jmv.1890300211. [DOI] [PubMed] [Google Scholar]
  13. Miller R. H., Robinson W. S. Common evolutionary origin of hepatitis B virus and retroviruses. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2531–2535. doi: 10.1073/pnas.83.8.2531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Munro H. N., Fleck A. Recent developments in the measurement of nucleic acids in biological materials. A supplementary review. Analyst. 1966 Feb;91(79):78–88. doi: 10.1039/an9669100078. [DOI] [PubMed] [Google Scholar]
  15. Müller W. E., Geisert M., Zahn R. K., Maidhof A., Bachmann M., Umezawa H. Potentiation of the cytostatic effect of bleomycin on L5178y mouse lymphoma cells by pepleomycin. Eur J Cancer Clin Oncol. 1983 May;19(5):665–670. doi: 10.1016/0277-5379(83)90183-9. [DOI] [PubMed] [Google Scholar]
  16. Müller W. E., Yamazaki Z. I., Sögtrop H. H., Zahn R. K. Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 2. Inhibition of mammalian and oncogenic viral polymerases. Eur J Cancer. 1972 Aug;8(4):421–428. doi: 10.1016/0014-2964(72)90127-2. [DOI] [PubMed] [Google Scholar]
  17. Müller W. E., Zahn R. K., Bittlingmaier K., Falke D. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems. Ann N Y Acad Sci. 1977 Mar 4;284:34–48. doi: 10.1111/j.1749-6632.1977.tb21935.x. [DOI] [PubMed] [Google Scholar]
  18. Offensperger W. B., Walter E., Offensperger S., Zeschnigk C., Blum H. E., Gerok W. Duck hepatitis B virus: DNA polymerase and reverse transcriptase activities of replicative complexes isolated from liver and their inhibition in vitro. Virology. 1988 May;164(1):48–54. doi: 10.1016/0042-6822(88)90618-6. [DOI] [PubMed] [Google Scholar]
  19. Pollard R. B., Smith J. L., Neal A., Gregory P. B., Merigan T. C., Robinson W. S. Effect of vidarabine on chronic hepatitis B virus infection. JAMA. 1978 Apr 21;239(16):1648–1650. [PubMed] [Google Scholar]
  20. Pugh J. C., Weber C., Houston H., Murray K. Expression of the X gene of hepatitis B virus. J Med Virol. 1986 Nov;20(3):229–246. doi: 10.1002/jmv.1890200305. [DOI] [PubMed] [Google Scholar]
  21. Reed K. C., Mann D. A. Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 1985 Oct 25;13(20):7207–7221. doi: 10.1093/nar/13.20.7207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rigby P. W., Dieckmann M., Rhodes C., Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977 Jun 15;113(1):237–251. doi: 10.1016/0022-2836(77)90052-3. [DOI] [PubMed] [Google Scholar]
  23. Sarin P. S., Taguchi Y., Sun D., Thornton A., Gallo R. C., Oberg B. Inhibition of HTLV-III/LAV replication by foscarnet. Biochem Pharmacol. 1985 Nov 15;34(22):4075–4079. doi: 10.1016/0006-2952(85)90392-2. [DOI] [PubMed] [Google Scholar]
  24. Sells M. A., Chen M. L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005–1009. doi: 10.1073/pnas.84.4.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sprengel R., Kuhn C., Manso C., Will H. Cloned duck hepatitis B virus DNA is infectious in Pekin ducks. J Virol. 1984 Dec;52(3):932–937. doi: 10.1128/jvi.52.3.932-937.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Suzuki S., Lee B., Luo W., Tovell D., Robins M. J., Tyrrell D. L. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides. Biochem Biophys Res Commun. 1988 Nov 15;156(3):1144–1151. doi: 10.1016/s0006-291x(88)80752-6. [DOI] [PubMed] [Google Scholar]
  27. Will H., Reiser W., Weimer T., Pfaff E., Büscher M., Sprengel R., Cattaneo R., Schaller H. Replication strategy of human hepatitis B virus. J Virol. 1987 Mar;61(3):904–911. doi: 10.1128/jvi.61.3.904-911.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yamashita Y., Koike K., Takaoki M., Matsuda S. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons. Microbiol Immunol. 1988;32(11):1119–1126. doi: 10.1111/j.1348-0421.1988.tb01476.x. [DOI] [PubMed] [Google Scholar]
  29. von Janta-Lipinski M., Langen P. Synthesis of 6-substituted thymine nucleosides. Nucleic Acids Symp Ser. 1981;(9):41–44. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES